Free Trial
LON:EKF

EKF Diagnostics (EKF) Share Price, News & Analysis

EKF Diagnostics logo
GBX 25.80 +0.45 (+1.78%)
As of 11:52 AM Eastern

About EKF Diagnostics Stock (LON:EKF)

Key Stats

Today's Range
25.36
25.90
50-Day Range
19.80
27
52-Week Range
18.40
32.90
Volume
165,392 shs
Average Volume
490,560 shs
Market Capitalization
£114.67 million
P/E Ratio
24.01
Dividend Yield
3.88%
Price Target
N/A
Consensus Rating
N/A

Company Overview

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Receive EKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKF Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

EKF Stock News Headlines

“You all just got a lot richer”
Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crashes. Do you think that’s an accident? When he threatens to “End the Fed” do you think he doesn’t know banking stocks will benefit? What about when he tells his followers, “Now is a good time to buy,” hours before relaxing tariffs and sending the market soaring? Is that an accident? Larry Benedict doesn’t think so. He thinks Trump knows what he’s doing… and believes he’s found the perfect tickers for everyday Americans to take advantage next time he triggers a big move.
EKF Diagnostics Holdings PLC (LYF.BE)
See More Headlines

EKF Stock Analysis - Frequently Asked Questions

EKF Diagnostics' stock was trading at GBX 27 at the beginning of the year. Since then, EKF shares have decreased by 4.4% and is now trading at GBX 25.80.
View the best growth stocks for 2025 here
.

EKF Diagnostics Holdings plc (LON:EKF) issued its quarterly earnings results on Tuesday, March, 25th. The company reported $1.38 earnings per share for the quarter. EKF Diagnostics had a net margin of 9.37% and a trailing twelve-month return on equity of 7.03%.

Shares of EKF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that EKF Diagnostics investors own include ERBA Diagnostics (ERBA), boohoo group (BOO), Lloyds Banking Group (LLOY), 888 (888), Abcam (ABC), ASOS (ASC) and Babcock International Group (BAB).

Company Calendar

Last Earnings
3/25/2025
Today
5/28/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:EKF
CIK
N/A
Fax
N/A
Employees
356
Year Founded
N/A

Profitability

Trailing P/E Ratio
24.01
Forward P/E Ratio
11.22
P/E Growth
N/A
Net Income
£4.68 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£49.91 million
Cash Flow
GBX 2.43 per share
Price / Cash Flow
10.64
Book Value
GBX 15.41 per share
Price / Book
1.67

Miscellaneous

Free Float
N/A
Market Cap
£114.67 million
Optionable
Not Optionable
Beta
0.57
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:EKF) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners